The medullary thyroid cancer drugs market is estimated to be valued at USD 156 Mn in 2024 and is expected to reach USD 315 Mn by 2031, growing at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. https://www.writerscafe.org/kirtitawale/blogs/Medullary-Thyroid-Cancer-Drugs-Market-is-Anticipated-to-Witness-High-Growth-Owing-to-Increasing-Prevalence-/244914/